Code*Number*Kind Code®(ifknown)
`
`
`
`U. S. PATENT DOCUMENTS
`
`Publication Date
`Nameof Patentee or
`Examiner
`i
`Pages, Columns, Lines, Where
`Initials*
`MM-DD-YYYY
`Applicant of Cited Document
`Relevant Passagesor Relevant
`Figures Appear
`
`.
`
`Document Number
`
`Number-Kind Code? “kw?
`
`US-20230041788
`
`02-09-2023
`
`OSTROW; Gregory I. et al.
`
`
`
`Approved for use through 11/30/2020. OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Complete if Known
`.
`Substitute for form 1449/PTO
`Application Number
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`
`
`Art Unit
`[ExaminerName__Not yet assigned
`Attorney Docket Number
`46682-701.319
`
`
`
`US-20230091109
`
`03-23-2023
`
`OSTROW; Gregory I. et al.
`
`US-20230092957
`
`03-23-2023
`
`OSTROW; Gregory I. et al.
`
`US-20230093205
`
`03-23-2023
`
`OSTROW; Gregory I. et al.
`
`
`
`FOREIGN PATENT DOCUMENTS
`
`Examiner
`Foreign Patent Document
`Publication
`Nameof Patentee or
`Pages, Columns, Lines,
`Initials*
`Date
`Applicant of Cited Document
`Where Relevant Passages
`MM-DD-YYYY
`Or Relevant Figures Appear
`
`
`
`
`
`|councuts?NaberrdCoe!iheomn)
`
`Examiner
`Signature
`
`
`
`Date
`Considered
`
`*EXAMINER: Initial if reference considered, whetherornot citation is in conformance with MPEP 609. Drawline through citation if not in conformance and not
`considered. Include copy of this form with next communication to applicant.
`‘ Applicant’s unique citation designation number(optional). ; See Kinds Codes of USPTO Patent
`Documents at www.uspto.gov or MPEP 901.04. : Enter Office that issued the document, by the two-letter code (WIPO Standard ST.3). . For Japanese patent documents, the
`indication of the year of the reign of the Emperor must precede the serial number of the patent document. *kind of document by the appropriate symbols as indicated on the
`document under WIPO Standard ST.16 if possible. Applicant is to place a check mark here if English language Translation is attached. This collection of information is required by
`37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to process) an application. Confidentiality is
`governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to complete, including gathering, preparing, and submitting the completed application
`form to the USPTO. Timewill vary depending uponthe individual case. Any comments on the amountof time you require to complete this form and/or suggestions for reducing this
`burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED
`FORMS TO THIS ADDRESS. SEND TO: Commissionerfor Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`If you need assistance in completing the form, call 1-800-PTO-9199 (1-800-786-9199) and select option 2.
`
`

`

`Approved for use through 11/30/2020. OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Complete if Known
`.
`Substitute for form 1449/PTO
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`17/721 ,831
`Application Number
`
`
`aU
`[ExaminerName__Not yet assigned
`Attorney Docket Number
`46682-701.319
`
`Examiner
`Initials*
`
`Include nameof the author(in CAPITAL LETTERS),title of the article(when appropriate), title of
`the item (book,magazine journal,serial,symposium, catalog, etc.) date,page(s), volume-issue
`number(s),publisher, city and/or country where published.
`
`
`;
`
`. Serial No. 18/055,940 Office Action dated April 26, 2023.
`
`
`
`HOWARD. Chapter 17: Special Solutions and Suspensions. Ansel's Pharmaceutical Dosage
`Forms and Drug Delivery Systems. pg. 607 (December 2013).
`
`U.S. Serial No. 16/785,411 Office Action dated March 28, 2023.
`
`. Serial No. 16/908,426 Office Action dated March 28, 2023.
`
`
`. Serial No. 17/335,490 Office Action dated July 7, 2023.
`
`. Serial No. 17/335,490 Office Action dated March 20, 2023.
`
`
`. Serial No. 17/894,882 Office Action dated March 14, 2023.
`
`
`. Serial No. 17/894,884 Office Action dated March 14, 2023.
`
`. Serial No. 17/894,885 Office Action dated March 14, 2023.
`
`
`
`
`U.S. Serial No 18/055,945 Office Action dated May 11, 2023.010 oO
`
`
`
`
`
`U.S. Serial No 18/055,949 Office Action dated May 11, 2023.011 oO
`
`
`
`012
`
`YAMetal. Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidencein
`Children: The LAMP2 RandomizedClinical Trial. JAMA 329(6):472-481 (2023).
`
`Examiner
`Signature
`
`Date
`Considered
`
`*EXAMINER: Initial if reference considered, whetheror not citation is in conformance with MPEP 609. Drawline through citation if not in conformance and not considered. Include
`copy of this form with next communication to applicant. ' Applicant's uniquecitation designation number (optional). * Applicant is to place a check mark here if English language
`Translation is attached. This collection of information is required by 37 CFR 1.98. The information is required to obtain or retain a benefit by the public whichis to file (and by the
`USPTOto process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to complete, including gathering,
`preparing, and submitting the completed application form to the USPTO. Timewill vary depending upon the individual case. Any comments on the amountof time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA
`22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissionerfor Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`If you need assistance in completing the form, call 1-800-PTO-9199 (1-800-786-9199) and select option 2.
`
`